Obstructive sleep apnea (OSA) afflicts at least 2 to 4% of the adult population.
![](https://www.enttoday.org/wp-content/uploads/springboard/image/2007_03_21.gif)
Obstructive sleep apnea (OSA) afflicts at least 2 to 4% of the adult population.
A form of light treatment called rhinophototherapy is being studied in the United States and may one day provide patients with allergic rhinitis and other diseases of the upper airway, such as nasal polyposis, with an alternative to standard therapies.
Mohamed A. Hamid, MD, PhD, believes, as a matter of principle, that an office vestibular examination is necessary before ordering electronystagmography (ENG)-or any other vestibular diagnostic tests, for that matter.
Dysphagia affects more than 20% of the population over the age of 50.
A consortium of 25 allergists and otorhinolaryngologists from five medical specialty societies in the United States has developed a guideline for designing clinical trials in the treatment of chronic rhinosinusitis.
Nonrandomized trials have suggested that intra-arterial delivery of chemoradiation would be superior to intravenous delivery of comparable chemoradiation in patients with inoperable head and neck cancer.
Harold (Rick) Pillsbury, MD, President-Elect of the Triological Society, has been predicting for 10 years that there would be a need to hire people to help extend otolaryngology practices—in other words, physician assistants (PAs) and nurse practitioners (NPs). “I was right. That makes me the soothsayer here,” he joked.